文献速递妇科

为何我们仍过度治疗宫颈癌Ia期?

Why do we continue to overtreat stage Ia carcinoma of the cervix?
PubMed 文献 · Am J Obstet Gynecol · 2017-05-15

本文综述了宫颈癌Ia2期的治疗现状,指出当前推荐广泛或改良广泛子宫切除术,但全球数据显示保守治疗可获得相似生存与复发率,作者据此建议广泛子宫切除术不应再作为所有Ia2期宫颈癌的标准治疗。

要点

  • 全球数据显示Ia2期宫颈癌保守治疗的生存率与复发率与广泛子宫切除术相似
  • 宫旁浸润和淋巴结转移虽增加复发风险,但在早期阶段相对少见
  • 作者建议广泛子宫切除术不应再作为所有Ia2期宫颈癌的标准治疗

核心结论

  • 基于所有综述数据,作者建议广泛子宫切除术不应再被视为所有Ia2期宫颈癌的标准治疗。

研究设计与样本

  • 本文为综述,旨在基于最新数据审视广泛子宫切除术在Ia2期宫颈癌适当治疗中是否仍有作用。

主要发现

  • 美国宫颈癌发病率低且下降,但每年超过4000例新发病例中近50%表现为早期阶段。
  • 估计每年有2200名女性接受广泛子宫切除术,其中许多人出现早期和晚期并发症。
  • 充分的组织学证据提示,宫旁浸润和淋巴结转移虽可增加复发风险,但在早期阶段相对少见。
  • 全球数据挑战广泛子宫切除术作为标准治疗,显示Ia2期宫颈癌保守治疗可获得相似的生存率和复发率。

临床怎么用

  • 作者建议广泛子宫切除术不应再作为所有Ia2期宫颈癌的标准治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The current recommended treatment for stage Ia2 cervical cancer is a radical or modified radical hysterectomy. Although in the United States the incidence of cervical cancer is low and declining, almost 50% of the >4000 new cases will present in early stages. An estimated 2200 women each year will undergo radical hysterectomy and many will have both early- and late-onset complications. The purpose of this review is to examine if there is still a role for radical hysterectomy in the proper treatment of stage Ia2 cervical cancer given most recent data. Sufficient histological evidence suggests that although parametrial involvement and lymph node metastases can increase the risk for recurrence, they are relatively uncommon at early stages. Worldwide data that challenge radical hysterectomy as standard of care have shown that conservative management of stage Ia2 cervical cancer results in similar survival and recurrence rates. It is the recommendation based on all reviewed data that radical hysterectomy should no longer be considered standard of care in all cases of stage Ia2 cervical cancer.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Buchanan T, Pierce JY, Graybill W, et al. Why do we continue to overtreat stage Ia carcinoma of the cervix? Am J Obstet Gynecol. 2017. PMID: 28522321. doi:10.1016/j.ajog.2017.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。